Standard: API 32-30240

MUTAGENICITY EVALUATION STUDIES IN THE RAT BONE MARROW CYTOGENETIC ASSAY - IN THE MOUSE LYMPHOMA FORWARD MUTATION ASSAY - HYDRODESULFURIZED KEROSINE API SAMPLE 81-07

This standard is available for individual purchase.

or unlock this standard with a subscription to IHS Standards Expert

IHS Standards Expert subscription, simplifies and expedites the process for finding and managing standards by giving you access to standards from over 370 standards developing organizations (SDOs).

FEATURES & BENEFITS
  • Maximize product development and R&D with direct access to over 1.6 million standards
  • Discover new markets: Identify unmet needs and discover next-generation technologies
  • Improve quality by leveraging consistent standards to meet customer and market requirements
  • Minimize risk: Mitigate liability and better understand compliance regulations
  • Boost efficiency: Speed up research, capture and reuse expertise
For additional product information, visit the IHS Standards Expert page.

HOW TO SUBSCRIBE
For more information or a custom quote, visit the IHS Contact Us page for regional contact information.
Scope:

ABSTRACT

Chromosome aberrations were determined in the bone marrow cells of Sprague-Dawley rats actively exposed intraperetoneally to API #81-07. Three dose levels were employed: 3.0 g/kg/day, 1.0 g/kg/day and 0.3 g/kg/day. Bone marrow was sampled 6, 24 and 48 hours after the acute dose. Five male and five female animals were exposed to each dose and negative ~ontrol level.

The structural aberration frequency in bone marrow cells of rats exposed to API #81-07 did not differ significantly from the negative control at any tested dose. The percentages of cells showing one or more structural aberrations or two or more structural aberrations were likewise similar to the negative controls, as was the frequency of numerical aberrations. These results were the same whether males or females or both sexes pooled were evaluated by the Student t-test. A concurrent positive control substance, triethylenemelamine, induced significant increases in structural aberrations in both the males and the females.

In vitro treatment of the mouse lymphoma L5178Y cell line did not induce Slgnificant increases in the mutant frequency at the thymidine kinase (TK) locus. The cells were exposed to API #81-07 for four hours both in the presence and absence of rat liver 59 metabolic activation. Treatments from 6.25 nl/ml to 37.5 nl/ml without activation and from 3.91 nl/ml to 62.5 nl/ml with S9 metabolic activation were assayed and a wide range of toxicities was induced without inducing significant increases in the mutant frequency. API #81-07 was therefore evaluated as inactive in the mouse lymphoma cell system.

Organization: American Petroleum Institute
Document Number: api 32-30240
Publish Date: 1984-12-01
Page Count: 44
Change Type: NEW ADDITION
Available Languages: EN
DOD Adopted: NO
ANSI Approved: NO
Most Recent Revision: YES
Current Version: NO
Status: Inactive
Advertisement
Advertisement
Advertisement
Advertisement